Le Bihan C, Bonaiti-Pellie C
Unité de Recherches d'Epidémiologie Génétique (U 155 INSERM), Paris, France.
Cancer Detect Prev. 1994;18(3):171-8.
Germline mutations of the tumor-suppressor gene p53 have been described in families with multiple neoplasms as Li-Fraumeni syndrome families, or in subjects with second malignant tumor. In order to evaluate the increase in risk of cancer due to these mutations, a family study is being carried out. In families with a proband who developed a cancer before age 16, we select those with at least one cancer before age 45 among first- and second-degree relatives of the proband. All family members are screened for p53 germline mutations if the proband is a carrier of a mutation. We present here a method to estimate the probability that a carrier of a p53 germline mutation develops a given malignant tumor at a given age. This method uses the principle of maximum likelihood estimation. It takes into account the fact that individuals are related within a family, that some of them are not genotyped for p53, and that families have been selected on the criterion of existence of cancer. Simulated data allowed us to validate the method.
肿瘤抑制基因p53的种系突变已在患有多种肿瘤的家庭中被描述,如李-佛美尼综合征家族,或在患有第二原发性恶性肿瘤的个体中被发现。为了评估由于这些突变导致的癌症风险增加,正在进行一项家庭研究。在有一名先证者在16岁之前患癌的家庭中,我们在先证者的一级和二级亲属中选择那些在45岁之前至少患有一种癌症的人。如果先证者是突变携带者,则对所有家庭成员进行p53种系突变筛查。我们在此提出一种方法,用于估计p53种系突变携带者在给定年龄患特定恶性肿瘤的概率。该方法使用最大似然估计原理。它考虑到个体在一个家庭中是有亲缘关系的,其中一些人没有进行p53基因分型,并且家庭是根据癌症的存在标准选择的。模拟数据使我们能够验证该方法。